SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-057777
Filing Date
2014-08-07
Accepted
2014-08-07 06:02:41
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a14-14216_110q.htm 10-Q 928022
2 EX-31.1 a14-14216_1ex31d1.htm EX-31.1 11917
3 EX-31.2 a14-14216_1ex31d2.htm EX-31.2 12675
4 EX-32.1 a14-14216_1ex32d1.htm EX-32.1 6549
5 EX-32.2 a14-14216_1ex32d2.htm EX-32.2 6521
  Complete submission text file 0001104659-14-057777.txt   4103090

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kbio-20140630.xml EX-101.INS 547226
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kbio-20140630.xsd EX-101.SCH 29485
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kbio-20140630_cal.xml EX-101.CAL 37113
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kbio-20140630_def.xml EX-101.DEF 83359
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT kbio-20140630_lab.xml EX-101.LAB 286258
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kbio-20140630_pre.xml EX-101.PRE 179893
Mailing Address 442 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 442 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35798 | Film No.: 141021620
SIC: 2834 Pharmaceutical Preparations